Prediction of Lymph Node Metastasis in Non-Small Cell Lung Carcinoma Using Primary Tumor Somatic Mutation Data [0.03%]
基于原发肿瘤体细胞突变数据的非小细胞肺癌淋巴结转移预测
Victor Lee,Nicholas S Moore,Joshua Doyle et al.
Victor Lee et al.
Purpose: Lymph node metastasis (LNM) significantly affects prognosis and treatment strategies in non-small cell lung cancer (NSCLC). Current diagnostic methods, including imaging and histopathology, have limited sensitivi...
Error Reduction in Leukemia Machine Learning Classification With Conformal Prediction [0.03%]
基于符合预测的 leukemia 机器学习分类误差降低方法研究
Mariya Lysenkova Wiklander,Dave Zachariah,Olga Krali et al.
Mariya Lysenkova Wiklander et al.
Purpose: Recent advances in machine learning have led to the development of classifiers that predict molecular subtypes of acute lymphoblastic leukemia (ALL) using RNA-sequencing (RNA-seq) data. Although these models have...
Impact of Providing an Automated Telephone Option to Report Weekly Patient-Reported Outcome Measures in the PRO-TECT Trial (AFT-39) on Disparity Gaps in Symptom Management and Outcomes [0.03%]
在PRO-TECT试验中提供自动电话选项以报告每周患者报告的结局措施对症状管理和结果差异的影响(AFT-39)
Angela M Stover,Allison M Deal,Brenda Ginos et al.
Angela M Stover et al.
Purpose: Many trials ask patients to complete patient-reported outcome measures (PROMs) via the web, excluding patients unable to use/access the Internet. The PRO-TECT trial (AFT-39, ClinicalTrials.gov identifier: NCT0324...
Randomized Controlled Trial
JCO clinical cancer informatics. 2025 May:9:e2500046. DOI:10.1200/CCI-25-00046 2025
Telehealth and Emergency Department Use Among Commercially Insured, Medicaid, and Medicare Patients Receiving Systemic Cancer Therapy in Washington State After COVID-19 [0.03%]
华盛顿州商业保险、医疗补助和医疗保险的癌症患者在COVID-19之后接受全身抗癌治疗时的远程医疗与急诊科使用情况
Scott D Ramsey,Qin Sun,Catherine R Fedorenko et al.
Scott D Ramsey et al.
Purpose: In oncology, telehealth services were adopted as a means of mitigating the risk of COVID-19 transmission. We hypothesized that Medicaid enrollees would have less access to telehealth than commercially insured or ...
Kenneth L Kehl
Kenneth L Kehl
Artificial intelligence (AI) is increasingly being applied to clinical cancer research, driving precision oncology objectives by gathering clinical data at scales that were not previously possible. Although small, domain-specific models hav...
User-Centered Design and Comparison of Two Electronic Health Record Tools to Support the Ordering of Crisantaspase Recombinant Chemotherapy [0.03%]
以用户为中心的设计及两种重组长春新碱化疗开药支持电子健康档案工具的比较
Renee Potashner,Tracey Taylor,Ally Sarna et al.
Renee Potashner et al.
Purpose: Chemotherapy ordering errors can have serious safety implications in pediatric oncology. Computerized provider order entry systems may reduce chemotherapy ordering errors. Crisantaspase recombinant (crisantaspase...
Comparative Study
JCO clinical cancer informatics. 2025 May:9:e2400306. DOI:10.1200/CCI-24-00306 2025
Prognostic Significance of the BALAD Serological Model in Systemic Therapies for Hepatocellular Carcinoma: A Personalized Approach to the Prediction of Survival Benefit [0.03%]
血清标志物BALAD预测系统抗肝癌治疗的预后价值：预测生存效益的个性化模型
Hidenori Toyoda,Atsushi Hiraoka,Hironori Ochi et al.
Hidenori Toyoda et al.
Purpose: The BALAD model, a scoring system for staging hepatocellular carcinoma (HCC), is based on five serum markers: bilirubin, albumin, lens culinaris agglutinin-reactive alpha-fetoprotein [AFP], AFP, and des-gamma-car...
Multicenter Study
JCO clinical cancer informatics. 2025 May:9:e2400175. DOI:10.1200/CCI-24-00175 2025
Assessing Algorithmic Fairness With a Multimodal Artificial Intelligence Model in Men of African and Non-African Origin on NRG Oncology Prostate Cancer Phase III Trials [0.03%]
NRG肿瘤学前列腺癌三期临床试验中利用多模态人工智能模型评估非洲裔和非非洲裔男性算法公平性
Mack Roach rd,Jingbin Zhang,Osama Mohamad et al.
Mack Roach rd et al.
Purpose: Artificial intelligence (AI) tools could improve clinical decision making or exacerbate inequities because of bias. African American (AA) men reportedly have a worse prognosis for prostate cancer (PCa) and are un...
Timing and Method of Patient-Provider Communication for Abnormal Hepatocellular Carcinoma Screening Results in Cirrhosis [0.03%]
肝硬化患者异常 hepatocellular carcinoma筛查结果的告知时机与方式
Jeremy Louissaint,Beverly Kyalwazi,John Deng et al.
Jeremy Louissaint et al.
Purpose: Patients with cirrhosis undergo frequent abdominal imaging including semiannual hepatocellular carcinoma (HCC) screening, with results released immediately via the patient portal. We characterized time from patie...
Application of Generative Artificial Intelligence for Physician and Patient Oncology Letters-AI-OncLetters [0.03%]
生成式人工智能在肿瘤学中的应用-OncoLetters-AI-OncoLetters
Adel Shahnam,Udit Nindra,Nadia Hitchen et al.
Adel Shahnam et al.
Purpose: Although large language models (LLMs) are increasingly used in clinical practice, formal assessments of their quality, accuracy, and effectiveness in medical oncology remain limited. We aimed to evaluate the abil...